Delehanty James B, Johnson Brandy J, Hickey Thomas E, Pons Thomas, Ligler Frances S
Center for Bio/Molecular Science and Engineering, Code 6900, US Naval Research Laboratory, Washington, DC 20375, USA.
J Nat Prod. 2007 Nov;70(11):1718-24. doi: 10.1021/np0703601. Epub 2007 Oct 20.
Proanthocyanidins (PACs), polyphenolic metabolites that are widely distributed in higher plants, have been associated with potential positive health benefits including antibacterial, chemotherapeutic, and antiatherosclerotic activities. In this paper, we analyze the binding of PACs from cranberries, tea, and grapes to lipopolysaccharide (LPS), a major component of the outer membrane of Gram-negative bacteria and the cause of several human illnesses. We demonstrate that in the case of cranberries, the most potent LPS-binding activity is contained within a PAC fraction composed of polymers with an average degree of polymerization of 21. The PAC fraction modestly inhibits the binding of LPS to the surface of HEK 293 cells expressing the full complement of LPS receptors (TLR4/MD2 and CD14), while it significantly abrogates the endocytosis of LPS. This PAC fraction also inhibits LPS-induced nuclear factor-kappaB activation in a manner that is not readily overcome by excess LPS. Such an effect is mediated through the inhibition of LPS interaction with TLR4/MD2 and the partial abrogation of LPS interaction with CD14. Importantly, PAC concentrations that mediate effective LPS neutralization elicit minimal in vitro cytotoxicity. Our results identify PACs as a new class of LPS-binding compound and suggest that they have potential utility in applications that necessitate either the purification and removal of LPS or the in vivo neutralization of LPS.
原花青素(PACs)是广泛分布于高等植物中的多酚类代谢产物,已被证实具有潜在的健康益处,包括抗菌、化疗和抗动脉粥样硬化活性。在本文中,我们分析了来自蔓越莓、茶和葡萄的PACs与脂多糖(LPS)的结合情况,LPS是革兰氏阴性菌外膜的主要成分,也是多种人类疾病的病因。我们证明,对于蔓越莓而言,最有效的LPS结合活性存在于一个PAC组分中,该组分由平均聚合度为21的聚合物组成。该PAC组分适度抑制LPS与表达完整LPS受体(TLR4/MD2和CD14)的HEK 293细胞表面的结合,同时显著消除LPS的内吞作用。该PAC组分还以一种不易被过量LPS克服的方式抑制LPS诱导的核因子-κB激活。这种效应是通过抑制LPS与TLR4/MD2的相互作用以及部分消除LPS与CD14的相互作用介导的。重要的是,介导有效LPS中和的PAC浓度在体外引起的细胞毒性最小。我们的结果将PACs鉴定为一类新的LPS结合化合物,并表明它们在需要纯化和去除LPS或体内中和LPS的应用中具有潜在用途。